5,686
Views
49
CrossRef citations to date
0
Altmetric
Research Article

Beneficial effects of an Andrographis paniculata extract and andrographolide on cognitive functions in streptozotocin-induced diabetic rats

, , &
Pages 1528-1538 | Received 13 Jan 2015, Accepted 04 Oct 2015, Published online: 25 Jan 2016

References

  • Abreu AC, McBain AJ, Simoes M. 2012. Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep. 29:1007–1021.
  • Agarwal R, Sulaiman SA, Mohamed M. 2005. Open label clinical trial to study adverse effects and tolerance to dry powder of the aerial part of Andrographis paniculata in patients type 2 with diabetes mellitus. Malays J Med Sci. 12:13–19.
  • Akbar S. 2011. Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern Med Rev. 16:66–77.
  • Apetz N, Munch G, Govindaraghavan S, Gyengesi E. 2014. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease – a translational perspective. CNS Neurol Disord Drug Targets. 13:1175–1191.
  • Bhutada P, Mundhada Y, Bansod K, Tawari S, Patil S, Dixit P, Umathe S, Mundhada D. 2011. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res. 220:30–41.
  • Borges A, Saavedra MJ, Simoes M. 2015. Insights on antimicrobial resistance, biofilms and the use of phytochemicals as new antimicrobial agents. Curr Med Chem. 22:2590–2614.
  • Butterfield DA, Di Domenico F, Barone E. 2014. Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta. 1842:1693–1706.
  • Chan SJ, Wong WS, Wong PT, Bian JS. 2010. Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia. Br J Pharmacol. 161:668–679.
  • Chandrasekaran CV, Thiyagarajan P, Deepak HB, Agarwal A. 2011. In vitro modulation of lps/calcimycin induced inflammatory and allergic mediators by pure compounds of Andrographis paniculata (king of bitters) extract. Int Immunopharmacol. 11:79–84.
  • Chao WW, Lin BF. 2010. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chin Med. 5:1–15.
  • Chen L, Magliano DJ, Zimmet PZ. 2012. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol. 8:228–236.
  • Davinelli S, Sapere N, Zella D, Bracale R, Intrieri M, Scapagnini G. 2012. Pleiotropic protective effects of phytochemicals in Alzheimer's disease. Oxid Med Cell Longev. 2012:1–11.
  • D'Hooge R, De Deyn PP. 2001. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev. 36:60–90.
  • Ducat L, Philipson LH, Anderson BJ. 2014. The mental health comorbidities of diabetes. JAMA. 312:691–692.
  • Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
  • Gudala K, Bansal D, Schifano F, Bhansali A. 2013. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig. 4:640–650.
  • HMPC. 2014. Committee on Herbal Medicinal Products (HMPC). Assessment report on Andrographis paniculata Nees, folium [Internet]; [cited 2015 Jun 3]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2014/06/WC500168112.pdf.
  • Hossain MS, Urbi Z, Sule A, Hafizur Rahman KM. 2014. Andrographis paniculata (Burm. F.) Wall. ex Nees: a review of ethnobotany, phytochemistry, and pharmacology. Sci World J. 2014:1–28.
  • Huang L, Su T, Li X. 2013. Natural products as sources of new lead compounds for the treatment of Alzheimer's disease. Curr Top Med Chem. 13:1864–1878.
  • Jayakumar T, Hsieh CY, Lee JJ, Sheu JR. 2013. Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid Based Complement Alternat Med. 2013:1–16.
  • Kakkar P, Das B, Viswanathan PN. 1984. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 21:130–132.
  • Kumar V, Thakur AK, Chatterjee SS. 2014. Perspective of Andrographis paniculata in neurological disorders. Clin Pharmacol Biopharm. S2:1–4.
  • Laparra JM, Sanz Y. 2010. Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res. 61:219–225.
  • Lin FL, Wu SJ, Lee SC, Ng LT. 2009. Antioxidant, antioedema and analgesic activities of Andrographis paniculata extracts and their active constituent andrographolide. Phytother Res. 23:958–964.
  • Low M, Khoo CS, Munch G, Govindaraghavan S, Sucher NJ. 2015. An in vitro study of anti-inflammatory activity of standardised Andrographis paniculata extracts and pure andrographolide. BMC Complement Altern Med. 15:1–9.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
  • Luck H. 1963. Catalaze. In: Bergmeyers HU, editor. Methods of enzymatic analysis. Weinheim and New York: Verlag Chemie, Academic Press. p. 885–888.
  • Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358.
  • Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H, Hambardzumyan E, Gabrielian E, Goukasova G, Wikman G, Wagner H. 2000. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination kan jang in rats and human. Phytomedicine. 7:351–364.
  • Panossian A, Wikman G. 2009. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol. 4:198–219.
  • Panossian A, Wikman G. 2013. Efficacy of Andrographis paniculata in upper respiratory tract infectious diseases and the mechanism of action. In: Wagner H, Ulrich-Merzenich G, editors. Evidence and rational based research on Chinese drugs. Vienna: Springer. p. 137–179.
  • Parixit B, Bharath C, Rajarajeshwari N, Ganapaty S. 2012. The genus Andrographis – a review. Int J Pharm Sci. 4:1835–1856.
  • Pawar VS, Shivakumar H. 2012. A current status of adaptogens: natural remedy to stress. Asian Pac J Trop Dis. 2:S480–S490.
  • Pekthong D, Martin H, Abadie C, Bonet A, Heyd B, Mantion G, Richert L. 2008. Differential inhibition of rat and human hepatic cytochrome p450 by Andrographis paniculata extract and andrographolide. J Ethnopharmacol. 115:432–440.
  • Radhika P, Annapurna A, Rao SN. 2012. Immunostimulant, cerebroprotective & nootropic activities of Andrographis paniculata leaves extract in normal & type 2 diabetic rats. . Indian J Med Res. 135:636–641.
  • Recio MC, Andujar I, Rios JL. 2012. Anti-inflammatory agents from plants: progress and potential. Curr Med Chem. 19:2088–2103.
  • Sareer O, Ahad A, Umar S. 2012. Prophylactic and lenitive effects of Andrographis paniculata against common human ailments: an exhaustive and comprehensive reappraisal. J Pharm Res Opin. 2:138–162.
  • Saxena RC, Singh R, Kumar P, Yadav SC, Negi MP, Saxena VS, Joshua AJ, Vijayabalaji V, Goudar KS, Venkateshwarlu K, et al. 2010. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold®) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. 17:178–185.
  • Serrano FG, Tapia-Rojas C, Carvajal FJ, Hancke J, Cerpa W, Inestrosa NC. 2014. Andrographolide reduces cognitive impairment in young and mature AβPPswe/PS-1 mice. Mol Neurodegener. 9:1–18.
  • Thakur AK, Chatterjee SS, Kumar V. 2014a. Therapeutic potential of traditionally used medicinal plant Andrographis paniculata (Burm. F.) against diabesity: an experimental study in rats. TANG (Humanitas Med). 4:1–8.
  • Thakur AK, Chatterjee SS, Kumar V. 2014b. Neuropsychopharmacology of a therapeutically used Andrographis paniculata extract: a preclinical study. Orient Pharm Exp Med. 14:181–191.
  • Thakur AK, Chatterjee SS, Kumar V. 2014c. Antidepressant-like activity of Andrographis paniculata in type-2 diabetic rats. Clin Pharmacol Biopharm. S2:1–9.
  • Thakur AK, Chatterjee SS, Kumar V. 2015. Adaptogenic potential of andrographolide: an active principle of the king of bitters (Andrographis paniculata). J Tradit Complement Med. 5:42–50.
  • Thakur AK, Shakya A, Husain GM, Emerald M, Kumar V. 2014. Gut-microbiota and mental health: current and future perspectives. J Pharmacol Clin Toxicol. 2:1–15.
  • Thakur AK, Soni UK, Rai G, Chatterjee SS, Kumar V. 2014. Protective effects of Andrographis paniculata extract and pure andrographolide against chronic stress-triggered pathologies in rats. Cell Mol Neurobiol. 34:1111–1121.
  • Wirth R, Bodi N, Maroti G, Bagyanszki M, Talapka P, Fekete E, Bagi Z, Kovacs KL. 2014. Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PLoS One. 9:e110440.
  • Xia YF, Ye BQ, Li YD, Wang JG, He XJ, Lin X, Yao X, Ma D, Slungaard A, Hebbel RP, et al. 2004. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol. 173:4207–4217.
  • Xu Y, Marshal RL, Mukkur TKS. 2006. An investigation on the antimicrobial activity of Andrographis paniculata extracts and andrographolide in vitro. Asian J Plant Sci. 5:527–530.
  • Ye L, Wang T, Tang L, Liu W, Yang Z, Zhou J, Zheng Z, Cai Z, Hu M, Liu Z. 2011. Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by p-glycoprotein. J Pharm Sci. 100:5007–5017.
  • Zhang Z, Jiang J, Yu P, Zeng X, Larrick JW, Wang Y. 2009. Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment. J Transl Med. 7:1–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.